FINLAY-FR-1, the vaccine project led by the Finlay Vaccine Institute, the Center for Molecular Immunology with the collaboration of the University of Havana’s Chemical and Biomolecular Synthesis Laboratory, has satisfactorily concluded the drug’s development stage and pre-clinical studies in animals, producing the scientific findings required to support authorization, by Cuba’s Center for State Control of Medications, Medical Equipment and Devices (Cecmed), to conduct clinical trials.
Cuban biotech products for COVID-19 treatment (Spanish only)
